Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedPublication details for a PubMed-listed article related to the study were added under Publications, including authors, title, journal, year, and DOI. A note explains that some entries are auto-filled from PubMed and may not be exclusively about the study.SummaryDifference0.2%

- Check9 days agoChange DetectedA new Revision: v3.5.4 appears on the page, replacing the previous Revision: v3.5.3. This update reflects a minor version change in the page's metadata rather than substantive content changes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer’s revision label has been updated from **v3.5.2** to **v3.5.3**, indicating a change to the site version rather than the study information.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.5.2. Removed Revision: v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision history updated to add v3.4.3 and remove v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.